ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000226287.3	Gefitinib	Bladder urothelial carcinoma	0.023740122	Sensitive
ENSG00000226287.3	Gefitinib	Breast invasive carcinoma	0.001765066	Sensitive